Keith Crandell - Jun 14, 2023 Form 4 Insider Report for 908 Devices Inc. (MASS)

Signature
/s/ Michael S. Turner, as Attorney-in-Fact
Stock symbol
MASS
Transactions as of
Jun 14, 2023
Transactions value $
$0
Form type
4
Date filed
6/16/2023, 05:52 PM
Previous filing
Apr 4, 2023
Next filing
Aug 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MASS Common Stock Options Exercise +4.77K +345.98% 6.15K Jun 14, 2023 Direct F1
holding MASS Common Stock 5.73M Jun 14, 2023 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MASS Restricted Stock Units Options Exercise $0 -4.77K -100% $0.00* 0 Jun 14, 2023 Common Stock 4.77K Direct F1, F3
transaction MASS Restricted Stock Units Award $0 +7.78K $0.00 7.78K Jun 15, 2023 Common Stock 7.78K Direct F4, F5
transaction MASS Stock Option (option to buy) Award $0 +12.1K $0.00 12.1K Jun 15, 2023 Common Stock 12.1K $8.68 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date.
F2 The securities are owned directly by ARCH Venture Fund VII, L.P. ("ARCH Fund VII"). The sole general partner of ARCH Fund VII is ARCH Venture Partners VII, L.P. ("ARCH Partners VII"), which may be deemed to be the beneficial owner of the securities held by ARCH Fund VII. The sole general partner of ARCH Partners VII is ARCH Venture Partners VII, LLC ("ARCH VII LLC"), which may be deemed to be the beneficial owner of the securities held by ARCH Fund VII. The reporting person is a managing director of ARCH VII LLC, and may be deemed to beneficially own the securities held by ARCH Fund VII. The reporting person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
F3 The RSUs became fully vested on June 14, 2023, the day prior to the 2023 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date.
F4 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested.
F5 The RSUs become fully vested on June 15, 2024 or the day prior to the 2024 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date.
F6 The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 15, 2023, subject to the reporting person's continued service through the applicable vesting date.